Wateska, Angela R <br/><br/>
Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in U.S. Populations.  [electronic resource] 

 -  American journal of preventive medicine  04 2020 
 - 487-495 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-2607 
<br/><br/><label>Standard No.: </label>10.1016/j.amepre.2019.10.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Black or African American--statistics & numerical data<br/>Aged<br/>Aged, 80 and over<br/>Cost-Benefit Analysis<br/>Female<br/>Humans<br/>Male<br/>Markov Chains<br/>Pneumococcal Infections--economics<br/>Pneumococcal Vaccines--administration & dosage<br/>Quality-Adjusted Life Years<br/>United States<br/>Vaccination--economics<br/>Vaccines, Conjugate--administration & dosage